
Last Price
52 Week Range
$12.47 - $30.44
Next Earnings Date
Feb 04 2026 (Estimate)
Next Earnings Date
Feb 04 2026 (Est.)
Last Price
Company Name | Form Type | Filed | View |
|---|---|---|---|
Teva Pharmaceutical Industries Limited | 8-K | December 11, 2025 | |
Teva Pharmaceutical Industries Limited | 10-Q | November 5, 2025 | |
Teva Pharmaceutical Industries Limited | 8-K | November 5, 2025 | |
Teva Pharmaceutical Industries Limited | 8-K | July 30, 2025 | |
Teva Pharmaceutical Industries Limited | 10-Q | July 30, 2025 | |
Teva Pharmaceutical Industries Limited | 8-K | June 5, 2025 | |
Teva Pharmaceutical Industries Limited | SD | June 2, 2025 | |
Teva Pharmaceutical Industries Limited | 8-K | May 28, 2025 | |
Teva Pharmaceutical Industries Limited | 8-K | May 22, 2025 | |
Teva Pharmaceutical Industries Limited | 8-K | May 7, 2025 | |
Teva Pharmaceutical Industries Limited | 10-Q | May 7, 2025 | |
Teva Pharmaceutical Industries Limited | DEFA14A | April 9, 2025 | |
Teva Pharmaceutical Industries Limited | DEF 14A | April 9, 2025 | |
Teva Pharmaceutical Industries Limited | ARS | April 9, 2025 | |
Teva Pharmaceutical Industries Limited | S3ASR | February 7, 2025 | |
Teva Pharmaceutical Industries Limited | 10-K | February 5, 2025 | |
Teva Pharmaceutical Industries Limited | 8-K | January 29, 2025 | |
Teva Pharmaceutical Industries Limited | 8-K | November 12, 2024 | |
Teva Pharmaceutical Industries Limited | 10-Q | November 6, 2024 | |
Teva Pharmaceutical Industries Limited | 8-K | November 6, 2024 | |
Teva Pharmaceutical Industries Limited | 8-K | July 31, 2024 | |
Teva Pharmaceutical Industries Limited | 10-Q | July 31, 2024 | |
Teva Pharmaceutical Industries Limited | 8-K | June 25, 2024 | |
Teva Pharmaceutical Industries Limited | 8-K | June 6, 2024 | |
Teva Pharmaceutical Industries Limited | SD | May 30, 2024 | |
Teva Pharmaceutical Industries Limited | 8-K | May 15, 2024 | |
Teva Pharmaceutical Industries Limited | 10-Q | May 8, 2024 | |
Teva Pharmaceutical Industries Limited | 8-K | May 8, 2024 | |
Teva Pharmaceutical Industries Limited | 8-K | April 18, 2024 | |
Teva Pharmaceutical Industries Limited | ARS | April 16, 2024 |
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.